Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M O, Nicoletto"'
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 16(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e031960ac91c2ffb34210908e0e356c
https://pubmed.ncbi.nlm.nih.gov/19692431
https://pubmed.ncbi.nlm.nih.gov/19692431
Autor:
Franco M. Muggia, M. Alvear, Elsa Reich, Tara Berman, W. C. Lai, M. O. Nicoletto, T. Safra, Izhak Haviv, L. Borgato
Publikováno v:
Annals of Oncology. 24:viii63-viii68
Background Epithelial ovarian cancer (EOC) patients with BRCA mutations have better prognosis than nonhereditary cases matched for histology and stage and age at diagnosis, especially Ashkenazi Jews (AJ). Materials and methods We retrospectively revi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e4a9e9a50925437810945dc257cb31d
https://doi.org/10.1093/annonc/mdt315
https://doi.org/10.1093/annonc/mdt315
Autor:
M. O. Nicoletto, M. E. Donach, L. Borgato, F. Angelini, G. Artioli, P. Azzoni, A. Perin, C. Barile, R. Bertorelle, A. Cecchetto, G. Cartei
Publikováno v:
Journal of Clinical Oncology. 24:15054-15054
15054 Background: The efficacy of PLD+Ox in pre-treated advanced EOC in third and fourth line suggests that the elevated survival in these patients might activate the p53 pathway. Methods: Inclusion criteria: Performance Status≤2, relapse or progre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e2f765d4bfa33fb2527dc1b96bd074b
https://doi.org/10.1200/jco.2006.24.18_suppl.15054
https://doi.org/10.1200/jco.2006.24.18_suppl.15054